Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Chad Deal, MD, Rheumatologist, Head, Center for Osteoporosis and Metabolic Bone Disease, Cleveland Clinic, discusses anabolic agents that build bone, the current parathyroid hormone drugs and the future…
NEW YORK (Reuters Health) – Cognitive impairment and indoor injury are both independent predictors of pre- and postoperative delirium in elderly patients with hip fracture, Norwegian researchers report.…
Charles Lockwood, MD, Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Services, Yale School of Medicine, discusses research initiatives looking at placental abruption and how it triggers…
Todd Schaeffer, MD, FACS, Assistant Clinical Professor of Otolaryngology, Mount Sinai School of Medicine, New York University School of Medicine, discusses endoscopic techniques and the use of direct…
Marsha Guess, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Services, Yale University, discusses pelvic organ prolapse in relation to vaginal birth versus cesarean section and summarizes that…
Emre Ui Seli, MD, Assistant Professor and Director Third Party Reproduction Program, Yale School of Medicine, discusses IVF, in vitro fertilization, which is the best treatment for infertility…
Emre U. Seli, MD, Assistant Professor and Director Third Party Reproduction Program, Yale School of Medicine, discusses IVF, the use of egg donors for women who cannot produce…
NEW YORK (Reuters Health) – Having a first-degree relative with breast cancer may slightly increase a person’s risk of colorectal cancer, Canadian researchers report in the International Journal…
NEW YORK (Reuters Health) – Ovarian- and uterine-conserving surgery appears to be safe in premenopausal women with stage IA or IC epithelial ovarian cancer, with no adverse impact…
NEW YORK (Reuters Health) – Due to hemoglobin degradation, delayed return of fecal occult blood tests (FOBTs) may miss colorectal adenomas and possibly also overt malignancy, according to…
